Background: Lupus miliaris disseminatus faciei (LMDF) is a benign condition characterized by a papular eruption located in the central face. Histologic studies of the papules show granulomatous infiltrates with central necrosis. The condition is self-limited and usually resolves within 1 to 2 years yet can be cosmetically debilitating, given the location and potential for scarring. Granulomatous periorificial dermatitis similarly affects the face with granulomatous lesions and may overlap clinically with LMDF.
Conclusion: This report highlights the challenge in differentiating and treating uncommon granulomatous facial dermatoses.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.2310/7750.2011.10034 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Lupus miliaris disseminatus with axillary localisation treated with isotretinoin.
Ann Dermatol Venereol
December 2024
Department of Dermatology, CHU de Bordeaux, Bordeaux, France. Electronic address:
Evaluation of Reflective Confocal Microscopy in Lupus Miliaris Disseminatus Faciei.
Photodermatol Photoimmunol Photomed
November 2024
Department of Pathology, Chengdu Second People's Hospital, Chengdu, Sichuan, China.
From drug therapy failures to laser therapy victory: A case report and literature review of lupus miliaris disseminatus faciei resolution.
Clin Case Rep
September 2024
Department of Dermatology, Rasool Akram Medical Complex Clinical Research Development Center (RCRDC), School of Medicine Iran University of Medical Sciences (IUMS) Tehran Iran.
Article Synopsis
- Pulsed dye laser (PDL) treatment has shown effectiveness in resolving lupus miliaris disseminatus faciei (LMDF) in cases where drug therapies have been unsuccessful.
- A 28-year-old male with persistent facial eruptions confirmed as LMDF received PDL after failed treatments with isotretinoin and methotrexate, leading to significant improvement without scarring.
- Early intervention with PDL may enhance treatment outcomes and reduce the risk of disease relapse, indicating the need for further research on laser therapy's role in managing LMDF.
Treatment of facial and axillary lupus miliaris with adalimumab.
Ann Dermatol Venereol
September 2024
Dermatology, CHU, Nantes, France.
Successful use of topical ivermectin in the treatment and maintenance of lupus miliaris disseminatus faciei.
Indian J Dermatol Venereol Leprol
July 2024
Department of Pathology, Indian Council of Medical Research National Institute of Pathology, Safdarjung Hospital Campus, New Delhi, India.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!